Plasminogen Activators Contribute to Impairment of Hypercapnic and Hypotensive Cerebrovasodilation After Cerebral Hypoxia/Ischemia in the Newborn Pig
- 1 October 2005
- journal article
- Published by Wolters Kluwer Health in Stroke
- Vol. 36 (10) , 2265-2269
Abstract
Background and Purpose— Babies are frequently exposed to hypoxia and ischemia during the perinatal period as a result of stroke or problems with delivery or respiratory management post delivery. The only U.S. Food and Drug Administration-approved treatment for acute stroke is the administration of tPA. Nonetheless, basic science studies indicate that tPA exhibits both beneficial and deleterious effects on central nervous system function. Cerebral hypoxia/ischemia (H/I) impairs dilation to hypercapnia and hypotension in the newborn pig. We investigated the role of exogenous and endogenous plasminogen activators (PA) in piglet hypercapnic and hypotensive dilator impairment after H/I. Methods— Responses to dilator stimuli were measured in chloralose-anesthetized piglets equipped with a closed cranial window before and after hypoxia (P o 2 35 mm Hg) and subsequent global cerebral ischemia. Data (n=6) were analyzed by repeated-measures analysis of variance. Results— Hypercapnic (P co 2 75 mm Hg) and hypotensive (mean arterial blood pressure decreased by 45%) pial artery dilation (PAD) was blunted after H/I and reversed to vasoconstriction in animals pretreated with tPA or uPA (10 −7 mol/L; 26±2, 11±1, and −4±1% for hypercapnia before, after H/I, and after H/I with tPA). In animals pretreated with EEIIMD (10 −7 mol/L), a peptide that binds uPA and tPA but does not affect proteolysis or soluble uPA receptor (suPAR, 10 −7 mol/L), which binds but does not affect the proteolytic activity of uPA. PAD induced by hypercapnia and hypotension was attenuated to a lesser extent (25±2 and 17±1% for hypercapnic PAD before and after H/I in EEIIMD-pretreated animals and 21±1 and 18±2% in suPAR-pretreated animals). Conclusions— These data show that exogenous PA administration potentiates the impairment of hypercapnic and hypotensive PAD that occurs after H/I. Inhibition of endogenous PA may ameliorate the impairment of PAD induced by hypercapnia and hypotension PAD that develops after hypoxic central nervous system injury of diverse etiologies.Keywords
This publication has 19 references indexed in Scilit:
- Plasminogen activators contribute to age-dependent impairment of NMDA cerebrovasodilation after brain injuryDevelopmental Brain Research, 2005
- Neonatal Brain InjuryNew England Journal of Medicine, 2004
- Altered NO Function Contributes to Impairment of uPA and tPA Cerebrovasodilation after Brain InjuryJournal of Neurotrauma, 2004
- The Low Density Lipoprotein Receptor-related Protein Is a Motogenic Receptor for Plasminogen Activator Inhibitor-1Journal of Biological Chemistry, 2004
- In vitro and in vivo effects of tPA and PAI-1 on blood vessel toneBlood, 2004
- Binding of Urokinase to Low Density Lipoprotein-related Receptor (LRP) Regulates Vascular Smooth Muscle Cell ContractionJournal of Biological Chemistry, 2002
- NOC/oFQ and NMDA Contribute to Piglet Hypoxic Ischemic Hypotensive Cerebrovasodilation ImpairmentPediatric Research, 2002
- Cerebral Sinovenous Thrombosis in ChildrenNew England Journal of Medicine, 2001
- Nonproteolytic Neuroprotection by Human Recombinant Tissue Plasminogen ActivatorScience, 1999
- Ischemia Alters Cerebral Vascular Responses to Hypercapnia and Acetylcholine in PigletsPediatric Research, 1989